Excess mortality occurred as the result of a number of causes, including overdose, injuries, and both infectious and noncommunicable diseases.
Alkermes has decided to expand the number of retail pharmacies and clinics where patients can receive access to Aristada (aripiprazole lauroxil) and Vivitrol (naltrexone extended-release injectable suspension).
Financial incentives improved X-waiver training completion and buprenorphine prescribing rates in emergency department physicians.
The estimated rate of past-year methamphetamine use was 6.6 per 1,000 adults during 2015 to 2018.
People who receive additional treatment following medically managed opioid withdrawal have reduced mortality compared with those who do not receive treatment.
Up to 75,000 more people could die from drug or alcohol misuse and suicide during the COVID-19 pandemic.
Few primary care physicians report interest in treating patients with opioid use disorder.
The USPSTF concludes that primary care-feasible behavioral interventions have a moderate net benefit for preventing tobacco use in children.
Smoking has shown a positive dose-response relationship with suicide-related behaviors after controlling for potential confounding factors such as psychiatric symptoms and alcohol consumption.
Despite conflicting evidence, a third of primary physicians do not perceive OUD medication to be more effective than nonmedication treatment.